Difebarbamate
 | |
| Systematic (IUPAC) name | |
|---|---|
| (5-ethyl-2,4,6-trioxo-5-phenyldihydropyrimidine-1,3(2H,4H)-diyl)bis-3-butoxypropane-1,2-diyl dicarbamate | |
| Clinical data | |
| Oral | |
| Identifiers | |
| 15687-09-9 | |
| None | |
| PubChem | CID 71880 |
| ChemSpider | 64896 |
| UNII | 7EE4K616KK |
| ChEMBL | CHEMBL2105563 |
| Chemical data | |
| Formula | C28H42N4O9 |
| 578.655 g/mol | |
|
SMILES
| |
| |
Difebarbamate (INN) is a tranquilizer of the barbiturate and carbamate families which is used in Europe as a component of a combination drug formulation referred to as tetrabamate (Atrium, Sevrium).[1][2]
See also
References
- ↑ Index nominum 2000: international drug directory. Taylor & Francis US. 2000. p. 333. ISBN 978-3-88763-075-1. Retrieved 26 November 2011.
- ↑ World Health Organization (2004). "The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substance" (PDF).
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||